What we cover (and why)

Practical questions around Modafinil and related nootropics, legality context, vendor performance signals, and community safety. YMYL topics are written cautiously with clear disclaimers.

How we research (source hierarchy)

1. Primary evidence: peer-reviewed studies, prescribing information, official notices.
2. Secondary analysis: respected medical/drug references; systematic reviews.
3. Community data: forum/Reddit posts, reader reports—treated as signals, never sole proof.

Every factual claim is traceable to a source; speculation is labeled.

Evidence standards for vendor evaluations

• Track repeated outcomes (delivery success, seizure/re-ship rates, support response).
• Normalize by timeframe and region; discard unverifiable one-offs.
• Weighting: reliability > quality > support > speed > price.
• Conflicts disclosed; partners cannot buy placement (see Disclosure).

Updates & maintenance

• Key guides: reviewed every 6–12 months or sooner when facts change.
• Reviews/leaderboard: adjusted when new data meaningfully shifts outcomes.
• Significant edits are logged on Corrections & Updates with dates and reasons.

Corrections & how to challenge an error

If you see an issue, share receipts/screenshots and the exact claim to review. I reply within 24 hours and update the Corrections log if a change is made.

Contact: /contact or post in the forum (see Community Guidelines).